.jpg?format=webp&width=780)
To assess European Association of Urology (EAU) risk groups for biochemical recurrence (BCR) of prostate cancer relative to prostate‐specific membrane antigen‐positron emission tomography (PSMA‐PET) status and oncological outcomes. A total of 137 patients were included, most of whom had EAU high‐risk disease (76%) and/or low PSA levels (80% <0.5 ng/mL) at the time of PSMA‐PET. In patients with post‐RP BCR, PSMA‐PET findings and receipt of SRT predicted EFS. In addition, in patients receiving SRT, PSMA status combined with EAU risk grouping was most predictive of EFS. These findings suggest that the EAU risk groups could be improved with the addition of PSMA‐PET.
Like
Save
Share